Conference Coverage

Merkel Cell Carcinoma Prognosis Linked to Vitamin D


 

AT THE ANNUAL CONGRESS OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Since ultraviolet light exposure figures in the pathogenesis of both of these serious skin cancers, one leading theory regarding the explanation for the left-sided predominance of Merkel cell carcinoma and melanoma involves increased driver-side UV exposure while operating motor vehicles. Dr. Kluger finds this explanation unlikely. Although steering wheels are placed on the left side of vehicles in Finland, as in the United States, left-side predominance of these skin cancers also has been reported in countries such as Scotland, where drivers stick to the left side of the road and the steering wheel is on the right, he noted.

In Finland, there was a significant excess of Merkel cell carcinomas on the left side in nearly every year of the 20-year study. That means if the skewed lateral distribution of the tumors is due to some as-yet-unidentified environmental factor, it’s a factor that hasn’t changed in 20 years, Dr. Kluger observed.

"For now it’s an interesting curiosity," he commented.

Both Dr. Kluger and Dr. Samimi reported having no financial conflicts.

Pages

Recommended Reading

Kaposi's Sarcoma Makes Unwelcome Return
MDedge Hematology and Oncology
Vemurafenib After Ipilimumab Linked to Rash
MDedge Hematology and Oncology
Medicare Okays Wound Plasma Gel for Clinical Trial Patients
MDedge Hematology and Oncology
SPECT/CT Before SLN Excision Improves Melanoma Survival
MDedge Hematology and Oncology
Dual Kinase Therapy Slows BRAF-Mutated Metastatic Melanoma
MDedge Hematology and Oncology
Health Care Professionals Tank in Cancer Survey
MDedge Hematology and Oncology
More Evidence Links Tanning Beds to Skin Cancer
MDedge Hematology and Oncology
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
MDedge Hematology and Oncology
Imaging Unwarranted in Primary Cutaneous Melanoma
MDedge Hematology and Oncology
Tuberous Sclerosis Skin Lesions Improved on Everolimus
MDedge Hematology and Oncology